Pub. Date : 2014 Apr 17
PMID : 24613527
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | RESULTS: In 2010, GP encounter rates on the day after receipt of the TIV manufactured by bioCSL (formerly CSL Biotherapies (Fluvax( )) were significantly higher than both bioCSL TIVs in the previous two years [rate ratio (RR) 1.9; 95% CI: 1.7-2.2] and Sanofi Pasteur TIV, Vaxigrip( ) [RR 1.6, 95% CI 1.4-1.7] in 2009-2010. | fluvax | chorionic somatomammotropin hormone like 1 | Homo sapiens |